Japan Post Capital Co. Ltd. — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
株式会社AIメディカルサービスai-ms.comin𝕏Oct 2019
AI Medical Service Inc. develops AI systems that support image-based diagnosis of endoscopy, primarily for detecting gastrointestinal cancers such as stomach and esophageal cancer.
AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP
Tomohiro Tada(Representative Director & Chief Medical Officer)inYasushi Takikawa(Representative Director)
Co-investorsGlobis Capital PartnersWiLSoftBank Vision FundSony Ventures CorporationDCI Partners Co. Ltd.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


